It has been widely reported that, in vivo, TrkB is spliced to generate truncated receptors that lack the cytoplamic kinase domain and that are expressed at different degrees in NB cells and tumors [23]–[26]. The gene discussed is NTRK2; the disease is neuroblastoma.